Asif Alavi, MD
Hematology · Detroit, MINPI 1790952562
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $14,443 of the $17,344 with a category attached, or 83.3%. 5 manufacturers reported payments, led by Vertex at 53.7% of the total. Reporting peaked in 2023 at $9,284 and has fallen 65.3% since, to $3,218 in 2025.
Across 22 payments — averaging $788.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vertex$9K
- Sanofi$3K
- Agios Pharmaceuticals, Inc.$2K
- Terumo BCT, Inc.$1K
- Sanofi-aventis U.S. LLC$1K
Across 243 payments — averaging $3335.64 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bioverativ Therapeutics Inc.$609K
- Sanofi US Services Inc.$74K
- Takeda Pharmaceuticals U.S.A., Inc.$50K
- Agios Pharmaceuticals, Inc.$44K
- Pharmacyclics LLC, An Abbvie Company$22K
- Incyte Corporation$9K
- plus $2K from 1 others
What the payments were for
- Consulting fees$14,44383%
- Travel & lodging$2,46714%
- Food & beverage$4343%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vertex | 10 | $9,313 |
| Sanofi | 2 | $3,425 |
| Agios Pharmaceuticals, Inc. | 6 | $1,694 |
| Terumo BCT, Inc. | 2 | $1,495 |
| Sanofi-aventis U.S. LLC | 2 | $1,418 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PYRUKYND$1,524
- Spectra Optia$1,495
How this compares
$17,344 in reported general payments places this provider in the 85th percentile of 50 hematology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxbrytaVoxelotor | 19 | $214,832 |
| PromactaEltrombopag Olamine | 14 | $203,012 |
| EliquisApixaban | 23 | $20,593 |
| Deferasirox | 23 | $6,227 |
| Enoxaparin Sodium | 13 | $2,638 |
| Morphine Sulfate ErMorphine Sulfate | 52 | $1,342 |
| Hydroxyurea | 24 | $921 |
| Hydromorphone Hcl | 40 | $715 |
| Oxycodone Hcl | 31 | $431 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 40 | $232 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 16 | $149 |
| Morphine Sulfate | 12 | $140 |
| Losartan Potassium | 11 | $95 |
| Duloxetine Hcl | 11 | $83 |
Paid to pharmacies, not to this prescriber.
Other hematology in Detroit
- Ahmad MattourDetroit$56K
- Paul SwerdlowDetroit$14K
- Andrew KinDetroit$9K
- Maria DiabDetroit$4K
- Hiba Jabbour-AidaDetroit$1K
- Craig ColeLansing$159K
- Matthew PiankoAnn Arbor$51K
- Sami MalekAnn Arbor$49K
- Yasmin KarimiAnn Arbor$47K
- Kristen PettitAnn Arbor$45K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.